Residual platelet reactivity in low-dose aspirin-treated patients with class 1 obesity.

Vascular Pharmacology
Silvia LeeThomas Gremmel

Abstract

Recent data suggest a decreased clinical efficacy of low-dose aspirin in patients weighing ≥70 kg. We therefore investigated the impact of body weight and class 1 obesity on thromboxane generation and platelet reactivity to arachidonic acid (AA) in 316 patients on dual antiplatelet therapy following angioplasty and stenting. Platelet surface expression of P-selectin and activated glycoprotein (GP) IIb/IIIa in response to AA were determined by flow cytometry as sensitive markers of platelet activation. Urinary 11-dehydro-thromboxane B2 (11-dehydro-TXB2) and serum TXB2 were measured by commercially-available immunoassays. On-treatment residual AA-inducible platelet aggregation was assessed by light transmission aggregometry (LTA), the VerifyNow aspirin assay and multiple electrode aggregometry (MEA). Class 1 obesity was independently associated with increased platelet surface expression of P-selectin and activated GPIIb/IIIa, but not with urinary 11-dehydro-TXB2, serum TXB2, and on-treatment platelet aggregation by all assays. Of all measured parameters, only MEA showed a positive albeit very weak correlation with body weight (r = 0.13, p = 0.02). Furthermore, the results of all tests did not differ significantly between patients...Continue Reading

References

Jul 18, 2002·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·I Mertens, L F Van Gaal
Dec 2, 2005·The New England Journal of Medicine·Carlo PatronoColin Baigent
Jul 3, 2007·The American Journal of Medicine·Wai-Hong ChenChu-Pak Lau
Oct 8, 2008·Circulation·John W EikelboomUNKNOWN Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) Investigators
Jul 28, 2009·Journal of Thrombosis and Haemostasis : JTH·C Patrono, B Rocca
Jan 28, 2010·Journal of Thrombosis and Haemostasis : JTH·L AyG Schernthaner
Sep 18, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·Hanneke J B H BeijersCoen D A Stehouwer
Sep 16, 2011·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·F SantilliG Davì
Oct 9, 2012·International Journal of Cardiology·Roza Badr EslamThomas Gremmel
Jan 24, 2013·Translational Research : the Journal of Laboratory and Clinical Medicine·Thomas GremmelChristoph W Kopp
Aug 30, 2014·Journal of the American College of Cardiology·Katharina MayerDirk Sibbing
Mar 2, 2016·Seminars in Thrombosis and Hemostasis·Thomas GremmelAlan D Michelson
Jul 18, 2018·Translational Research : the Journal of Laboratory and Clinical Medicine·Thomas GremmelSimon Panzer
Jul 27, 2018·Research and Practice in Thrombosis and Haemostasis·Thomas GremmelDeepak L Bhatt
Apr 2, 2019·Journal of Thrombosis and Haemostasis : JTH·Giovanna PetrucciBianca Rocca
Dec 22, 2019·Vascular Pharmacology·Philipp MourikisAmin Polzin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.